First description of OXA-48-producing Escherichia coli and the pandemic clone ST131 from patients hospitalised at a military hospital in Algeria

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 33, Issue 9, 2014, Pages 1641-1646

  Agabou, A ^a,b   Pantel, A ^b,c   Ouchenane, Z ^a   Lezzar, N ^a   Khemissi, S ^a   Satta, D ^a   Sotto, A ^b   Lavigne, J P ^b,c  

^a Universite Mentouri Constantine   (Algeria)

^b INSERM   (France)

^c DEPARTMENT OF NEUROLOGY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEMASE; ERTAPENEM; EXTENDED SPECTRUM BETA LACTAMASE; ANTIINFECTIVE AGENT; BETA LACTAMASE; OXACILLINASE; TRANSPOSON;

ADOLESCENT; ADULT; AGED; ALGERIA; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CHILD; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; FEMALE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR EPIDEMIOLOGY; MOLECULAR PHYLOGENY; NONHUMAN; PANDEMIC; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PUBLIC HOSPITAL; SEROTYPING; TRANSPOSON; TUNISIA; CLASSIFICATION; ENZYMOLOGY; GENETICS; GENOTYPE; INFANT; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; MOLECULAR TYPING; MULTIDRUG RESISTANCE; PHYLOGENY; PRESCHOOL CHILD; SECRETION (PROCESS); YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ALGERIA; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CHILD; CHILD, PRESCHOOL; DNA TRANSPOSABLE ELEMENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; GENOTYPE; HOSPITALS, MILITARY; HUMANS; INFANT; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MOLECULAR TYPING; PHYLOGENY; SEROTYPING; YOUNG ADULT;

EID: 84906044160     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-014-2122-y     Document Type: Article

References (34)

1. Cantón R, Coque TM (2006) The CTX-M β-lactamase pandemic. Curr Opin Microbiol 9:466-475
2. Nicolas-Chanoine MH, Blanco J, Leflon-Guibout V, Demarty R, Alonso MP, Caniça MM, Park YJ, Lavigne JP, Pitout J, Johnson JR (2008) Intercontinental emergence of Escherichia coli clone O25: H4-ST131 producing CTX-M-15. J Antimicrob Chemother 61:273-281
3. Nordmann P, Naas T, Poirel L (2011) Global spread of carbapenemase- producing Enterobacteriaceae. Emerg Infect Dis 17:1791-1798
4. Girlich D, Bouihat N, Poirel L, Benouda A, Nordmann P (2014) High rate of faecal carriage of extended-spectrum β-lactamase and OXA-48 carbapenemase-producing Enterobacteriaceae at a University hospital in Morocco. Clin Microbiol Infect 20:350-354
5. Saïdani M, Hammami S, Kammoun A, Slim A, Boutiba-Ben Boubaker I (2012) Emergence of carbapenem-resistant OXA-48 carbapenemase-producing Enterobacteriaceae in Tunisia. J Med Microbiol 61:1746-1749
6. Jarlier V, Nicolas MH, Fournier G, Philippon A (1988) Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis 10:867-878
7. Poirel L, Walsh TR, Cuvillier V, Nordmann P (2011) Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis 70:119-123
8. Cattoir V, Poirel L, Rotimi V, Soussy CJ, Nordmann P (2007) Multiplex PCR for detection of plasmid-mediated quinolone resistance qnr genes in ESBL-producing enterobacterial isolates. J Antimicrob Chemother 60:394-397 (Pubitemid 47243891)
9. Yamane K, Wachino J, Suzuki S, Arakawa Y (2008) Plasmid-mediated qepA gene among Escherichia coli clinical isolates from Japan. Antimicrob Agents Chemother 52:1564-1566 (Pubitemid 351522037)
10. Clermont O, Bonacorsi S, Bingen E (2000) Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 66:4555-4558
11. Clermont O, Johnson JR, Menard M, Denamur E (2007) Determination of Escherichia coli O types by allele-specific polymerase chain reaction: application to the O types involved in human septicemia. Diagn Microbiol Infect Dis 57:129-136 (Pubitemid 46135872)
12. Poirel L, Bonnin RA, Nordmann P (2012) Genetic features of the widespread plasmid coding for the carbapenemase OXA-48. Antimicrob Agents Chemother 56:559-562
13. Aubert D, Naas T, Héritier C, Poirel L, Nordmann P (2006) Functional characterization of IS1999, an IS4 family element involved in mobilization and expression of beta-lactam resistance genes. J Bacteriol 188:6506-6514 (Pubitemid 44412060)
14. Lavigne JP, Marchandin H, Delmas J, Bouziges N, Lecaillon E, Cavalie L, Jean-Pierre H, Bonnet R, Sotto A (2006) qnrA in CTX-M-producing Escherichia coli isolates from France. Antimicrob Agents Chemother 50:4224-4228 (Pubitemid 44865178)
15. Baba Ahmed-Kazi Tani Z, Decré D, Genel N, Boucherit-Otmani Z, Arlet G, Drissi M (2013) Molecular and epidemiological characterization of enterobacterial multidrug-resistant strains in Tlemcen Hospital (Algeria) (2008-2010). Microb Drug Resist 19:185-190
16. Hammerum AM, Larsen AR, Hansen F, Justesen US, Friis-Møller A, Lemming LE, Fuursted K, Littauer P, Schønning K, Gahrn-Hansen B, Ellermann-Eriksen S, Kristensen B (2012) Patients transferred from Libya to Denmark carried OXA-48-producing Klebsiella pneumoniae, NDM-1-producing Acinetobacter baumannii and meticillin-resistant Staphylococcus aureus. Int J Antimicrob Agents 40:191-192
17. Giani T, Conte V, Di Pilato V, Aschbacher R, Weber C, Larcher C, Rossolini GM (2012) Escherichia coli from Italy producing OXA-48 carbapenemase encoded by a novel Tn1999 transposon derivative. Antimicrob Agents Chemother 56:2211-2213
18. Kilic A, Aktas Z, Bedir O, Gumral R, Bulut Y, Stratton C, Tang YW, Basustaoglu AC (2011) Identification and characterization of OXA-48 producing, carbapenem-resistant Enterobacteriaceae isolates in Turkey. Ann Clin Lab Sci 41:161-166
19. Matar GM, Cuzon G, Araj GF, Naas T, Corkill J, Kattar MM, Nordmann P (2008) Oxacillinase-mediated resistance to carbapenems in Klebsiella pneumoniae from Lebanon. Clin Microbiol Infect 14:887-888
20. Pitart C, Solé M, Roca I, Fàbrega A, Vila J, Marco F (2011) First outbreak of a plasmid-mediated carbapenem-hydrolyzing OXA-48 β-lactamase in Klebsiella pneumoniae in Spain. Antimicrob Agents Chemother 55:4398-4401
21. Poirel L, Abdelaziz MO, Bernabeu S, Nordmann P (2013) Occurrence of OXA-48 and VIM-1 carbapenemase-producing Enterobacteriaceae in Egypt. Int J Antimicrob Agents 41:90-91
22. Poirel L, Potron A, Nordmann P (2012) OXA-48-like carbapenemases: the phantom menace. J Antimicrob Chemother 67:1597-1606
23. Potron A, Poirel L, Rondinaud E, Nordmann P (2013) Intercontinental spread of OXA-48 beta-lactamase-producing Enterobacteriaceae over a 11-year period, 2001 to 2011. Euro Surveill 18(31). pii: 20549
24. Robin F, Aggoune-Khinache N, Delmas J, Naim M, Bonnet R (2010) Novel VIM metallo-beta-lactamase variant from clinical isolates of Enterobacteriaceae from Algeria. Antimicrob Agents Chemother 54:466-470
25. Amhis W, Boudjelti I, Sahel N, Benbedka L, Benmesbah S, Hamzi W (2011) Prevalence and antibiotic resistance of the ESBL producing Enterobacteria strains isolated in Bologhine hospital during the years 2007-2010. BMC Proc 5:P136
26. Ramdani-Bouguessa N, Mendonça N, Leitão J, Ferreira E, Tazir M, Caniça M (2006) CTX-M-3 and CTX-M-15 extended-spectrum beta-lactamases in isolates of Escherichia coli from a hospital in Algiers, Algeria. J Clin Microbiol 44:4584-4586 (Pubitemid 44937102)
27. Seo MR, Kim J, Kim YJ, Wie SH, Cho YK, Lim SK, Lee JS, Kweon KT, Lee H, Cheong HJ, Park DW, Ryu SY, Pai H (2013) Characteristics of ciprofloxacin- resistant Escherichia coli clones from community-acquired urinary tract infection in Korea. In: Abstracts of the 1st International Interscience Conference on Infection and Chemotherapy (ICIC 2013), Seoul, Korea, November 2013. Abstract A-017, p. 113. Korean Society of Infectious Diseases, Seoul, Korea
28. Naseer U, Haldorsen B, Simonsen GS, Sundsfjord A (2010) Sporadic occurrence of CMY-2-producingmultidrug-resistant Escherichia coli of ST-complexes 38 and 448, and ST131 in Norway. Clin Microbiol Infect 16:171-178
29. Karfunkel D, Carmeli Y, Chmelnitsky I, Kotlovsky T, Navon-Venezia S (2013) The emergence and dissemination of CTX-Mproducing Escherichia coli sequence type 131 causing communityonset bacteremia in Israel. Eur J Clin Microbiol Infect Dis 32:513-521
30. Bielaszewska M, Mellmann A, Bletz S, Zhang W, Köck R, Kossow A, Prager R, Fruth A, Orth-Höller D, Marejková M, Morabito S, Caprioli A, Piérard D, Smith G, Jenkins C, Curová K, Karch H (2013) Enterohemorrhagic Escherichia coli O26:H11/H-: a new virulent clone emerges in Europe. Clin Infect Dis 56:1373-1381
31. Bouchakour M, Zerouali K, Gros Claude JD, Amarouch H, El Mdaghri N, Courvalin P, Timinouni M (2010) Plasmid-mediated quinolone resistance in expanded spectrum beta lactamase producing Enterobacteriaceae in Morocco. J Infect Dev Ctries 4:799-803
32. Hassan WM, Hashim A, Domany RA (2012) Plasmid mediated quinolone resistance determinants qnr, aac(6′)-Ib-cr, and qep in ESBL-producing Escherichia coli clinical isolates from Egypt. Indian J Med Microbiol 30:442-447
33. Gharout-Sait A, Touati A, Benallaoua S, Guillard T, Brasme L, Madoux J, De Champs C (2012) CTX-M from community-acquired urinary tract infections in Algeria. Afr J Microbiol Res 6: 5306-5313
34. Iabadene H, Messai Y, Ammari H, Ramdani-Bouguessa N, Lounes S, Bakour R, Arlet G (2008) Dissemination of ESBL and Qnr determinants in Enterobacter cloacae in Algeria. J Antimicrob Chemother 62:133-136 (Pubitemid 351865885)